ATE432469T1 - Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs - Google Patents
Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebsInfo
- Publication number
- ATE432469T1 ATE432469T1 AT05799643T AT05799643T ATE432469T1 AT E432469 T1 ATE432469 T1 AT E432469T1 AT 05799643 T AT05799643 T AT 05799643T AT 05799643 T AT05799643 T AT 05799643T AT E432469 T1 ATE432469 T1 AT E432469T1
- Authority
- AT
- Austria
- Prior art keywords
- boris
- process based
- immune reaction
- detecting cancer
- reaction against
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61179804P | 2004-09-21 | 2004-09-21 | |
PCT/US2005/033796 WO2006034335A2 (en) | 2004-09-21 | 2005-09-21 | Method of detecting cancer based on immune reaction to boris |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE432469T1 true ATE432469T1 (de) | 2009-06-15 |
Family
ID=36090647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05799643T ATE432469T1 (de) | 2004-09-21 | 2005-09-21 | Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs |
Country Status (6)
Country | Link |
---|---|
US (1) | US7785814B2 (de) |
EP (1) | EP1802972B1 (de) |
AT (1) | ATE432469T1 (de) |
DE (1) | DE602005014659D1 (de) |
ES (1) | ES2325866T3 (de) |
WO (1) | WO2006034335A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006082414A1 (en) * | 2005-02-03 | 2006-08-10 | Cancer Research Technology Limited | Detection and diagnosis of cancer |
AU2007289149B2 (en) | 2006-08-31 | 2013-08-15 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | BORIS isoforms and methods of detecting and treating disease |
US10415094B2 (en) | 2016-10-06 | 2019-09-17 | HelicalHelp LLC | Risk stratification method for a patient having a polymorphism |
EP3914296A4 (de) * | 2019-01-25 | 2022-11-30 | Mayo Foundation for Medical Education and Research | Bewertung und behandlung von keimzelltumoren und paranoplastischer autoimmunität |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
EP1997894B1 (de) * | 1992-02-06 | 2011-03-30 | Novartis Vaccines and Diagnostics, Inc. | Biosynthetisches Bindeprotein für Tumormarker |
WO2003072799A2 (en) | 2002-02-22 | 2003-09-04 | The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Brother of the regulator of imprinted sites (boris) |
US20040152877A1 (en) * | 2002-03-14 | 2004-08-05 | Hillman Jennifer L. | Nucleic acid-associated proteins |
US7579452B2 (en) | 2003-08-25 | 2009-08-25 | Oncomune, Llc | Cancer vaccine based on brother of regulator of imprinted sites molecule |
-
2005
- 2005-09-21 AT AT05799643T patent/ATE432469T1/de not_active IP Right Cessation
- 2005-09-21 ES ES05799643T patent/ES2325866T3/es active Active
- 2005-09-21 US US11/575,732 patent/US7785814B2/en active Active
- 2005-09-21 DE DE602005014659T patent/DE602005014659D1/de active Active
- 2005-09-21 EP EP05799643A patent/EP1802972B1/de active Active
- 2005-09-21 WO PCT/US2005/033796 patent/WO2006034335A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US7785814B2 (en) | 2010-08-31 |
EP1802972B1 (de) | 2009-05-27 |
WO2006034335A3 (en) | 2006-08-03 |
EP1802972A2 (de) | 2007-07-04 |
ES2325866T3 (es) | 2009-09-22 |
DE602005014659D1 (de) | 2009-07-09 |
US20080095805A1 (en) | 2008-04-24 |
WO2006034335A2 (en) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE549624T1 (de) | Verfahren und zusammensetzungen zur diagnose und behandlung von grippe | |
DE602006002809D1 (de) | Verfahren zur erkennung eines ovarialkarzinoms | |
ATE541054T1 (de) | Bio-barcode erkennung für zielmoleküle | |
ATE548467T1 (de) | Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände | |
ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
ATE515488T1 (de) | Click-chemie zur herstellung von reportermolekülen | |
PH12015502849A1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
ATE431854T1 (de) | Auf bio-barcodes beruhender nachweis von zielanalyten | |
ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
ATE456666T1 (de) | Verfahren zur auswertung von ribonukleotidsequenzen | |
ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
ATE495243T1 (de) | Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung | |
WO2009007846A3 (en) | Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins | |
ATE462803T1 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
MY145455A (en) | Diagnostic biomolecule(s) | |
ATE432469T1 (de) | Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
ATE554388T1 (de) | Verfahren und immunabsorbentien zur spezifischen detektion und absorption zöliakie- und dermatitis herpetiformis assoziierter antikörper | |
CY1117709T1 (el) | Αναλυτικη μεθοδος για μορια fab και fab' | |
MX341181B (es) | Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta. | |
WO2010000467A8 (en) | Asc as a marker for lung cancer | |
ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |